Trial Profile
A Study to Investigate the Effect of Bupivacaine Liposomal Injectable Suspension on Hospital Costs, Length of Stay, and Discharge Status in Patients Undergoing Total Knee Arthroplasty at High Use Institutions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Dec 2018 New trial record
- 27 Nov 2018 According to a Pacira Pharmaceuticals media release, results of this study were published in The Journal of Medical Economics.
- 27 Nov 2018 New results from this study presented in a Pacira Pharmaceuticals media release.